Latest Conference Articles

Your unrestricted view into eyecare conferences across the spectrum. Gain exclusive access to Ophthalmology Times Europe® expert-led conference coverage from major meetings throughout the year featuring articles, videos, and insights shared by prominent experts of the ophthalmic community

Disrupting the glaucoma treatment paradigm with novel femtosecond laser from ViaLase

Disrupting the glaucoma treatment paradigm with novel femtosecond laser from ViaLase

October 16th 2022, 7:50am

AAO

Shawn O'Neil of ViaLase shares updates on the company's femtosecond laser, image-guided, high-precision trabeculotomy (FLigHT) treatment.

Trukera Medical rebranding ushers in new era of expansion into cornea market

Trukera Medical rebranding ushers in new era of expansion into cornea market

October 15th 2022, 7:16am

AAO

Adam Szaronos, President and CEO of Trukera Medical, discusses the recent rebranding of TearLab as well as the launch of the ScoutPro Osmolarity System.

2-year data in contralateral eye evaluation gives edge to iStent inject over Hydrus stent

2-year data in contralateral eye evaluation gives edge to iStent inject over Hydrus stent

October 12th 2022, 7:02am

AAO

At AAO 2022, Dr Mitch Shultz provides discourse on iStent inject vs Hydrus contralateral eye evaluation data.

AAO recap: Clinical trial updates, new innovations presented at America's biggest ophthalmic conference

AAO recap: Clinical trial updates, new innovations presented at America's biggest ophthalmic conference

October 5th 2022, 7:14am

AAO

A combination of posters, podium presentations and instructional courses provided invaluable revelations to the ophthalmic community.

Optogenetics approach could restore visual function in retinitis pigmentosa

Optogenetics approach could restore visual function in retinitis pigmentosa

October 4th 2022, 7:24am

EURETINA

Companies are exploring light-sensitive proteins method in patients with advanced disease.

No negative effects in DMO patients reported following pandemic-imposed health care restrictions

No negative effects in DMO patients reported following pandemic-imposed health care restrictions

October 3rd 2022, 7:15pm

AAO

The data analysis showed that the macular thickness decreased across all time periods and in all macular regions for all terciles.

Risk factors for developing rhegmatogenous retinal detachments in fellow eyes identified in study

Risk factors for developing rhegmatogenous retinal detachments in fellow eyes identified in study

October 3rd 2022, 5:40pm

AAO

Patients with a unilateral rhegmatogenous retinal detachment frequently ask about the risk of developing an RRD in their fellow eye.

Increased smoking-related ocular symptoms linked to cigarettes than electronic cigarettes

Increased smoking-related ocular symptoms linked to cigarettes than electronic cigarettes

October 3rd 2022, 1:30pm

AAO

Those who used both traditional and electronic cigarettes reported severe to very severe ophthalmic symptoms.

Pooled TENAYA, LUCERNE Phase 3 data reports safety, efficacy, lower treatment burden with faricimab for nAMD

Pooled TENAYA, LUCERNE Phase 3 data reports safety, efficacy, lower treatment burden with faricimab for nAMD

October 3rd 2022, 7:20am

AAO

The AVONELLE-X long-term extension study will continue to evaluate the efficacy, durability and safety of faricimab in patients with neovascular AMD.

Younger patients often require repeat corneal crosslinking, study finds

Younger patients often require repeat corneal crosslinking, study finds

October 2nd 2022, 6:58pm

AAO

At the 2022 American Academy of Ophthalmology meeting, Dr Philip Dockery, MPH, presents, "Effectiveness of corneal crosslinking in young patients."